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Summary
Background:  India  has  a high  tuberculosis  (TB)  burden.  A  signiﬁcant  percentage  of
TB  patients  are  human  immunodeﬁciency  virus  (HIV)  positive.  As  the  HIV  epidemic
is  fueling  the  global  TB  epidemic,  the  prevalence  of  the  virus  in  TB  patients  is  a
sensitive  indicator  of  the  spread  of  HIV  into  the  general  population  in  many  regions.
The  aim  of  this  study  was  to  determine  the  prevalence  of  HIV—TB  co-infection  among
a  less  studied  population  of  Eastern  India.
Materials  and  methods:  A  cross-sectional  record  analysis  study  covering  the  period
from  2000  to  2011  was  conducted  at  Central  Hospital  of  South  Eastern  Railway,
Garden  Reach,  Kolkata,  India.  All  tuberculosis  patients  consenting  for  HIV  testing
were  included  in  the  study  after  obtaining  ethical  clearance  from  the  institution.
The  TB  diagnosis  was  performed  using  clinical  examination,  sputum  acid-fast  bacillus
(AFB)  smear  and  chest  radiography.  HIV-positive  cases  were  screened  using  an  initial
HIV  tridot  test,  followed  by  repetitive  tests  using  a  Micro  ELISA  HIV  Kit  for  HIV  1  and
HIV  2  antigen.
Results:  Overall,  50  (12.3%)  of  the  consenting  406  TB  patients  were  HIV  positive.  Of
these  406  patients,  44%  had  pulmonary  TB,  and  56%  had  extrapulmonary  TB  (EPTB).
Coughing  was  the  most  common  symptom  (90%),  followed  by  fever  (78%).  Pleural
effusion  (60.7%)  was  the  most  common  form  observed  in  the  EPTB  cases.
Conclusions:  The  prevalence  of  HIV—TB  co-infection  was  12.3%.  Consequently,  all
TB  patients  should  be  assessed  for  HIV  risk  factors  and  counseled  to  undergo  HIV
testing.  Conversely,  all  HIV-positive  cases  should  be  screened  for  TB.
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Hrevalence  of  HIV  infection  among  tuberculosis  pat
ntroduction
outheast  Asia  is  known  to  have  the  highest  world-
ide tuberculosis  (TB)  burden,  contributing  35%
o the  global  TB  incidence.  Of  the  11  countries
n Southeast  Asia,  5  (Bangladesh,  India,  Indonesia,
yanmar and  Thailand)  are  among  the  22  countries
ith  the  highest  TB  burden  [1]. According  to  a
010 World  Health  Organization  (WHO)  global  TB
eport, the  annual  incidence  of  TB  was  9.4  mil-
ion cases,  of  which  2  million  cases  were  from
ndia. India  is  17th  among  the  22  countries  with
he highest  TB  incidence  rates.  According  to  a
004 WHO  report,  TB  ranked  the  7th  leading  cause
f death  worldwide,  accounting  for  2.5%  of  all
eaths. Furthermore,  of  the  9.4  million  diagnosed
ases of  TB  in  2009,  an  estimated  1.1  million
12%) were  human  immunodeﬁciency  virus  (HIV)
ositive,  with  78%  in  Africa  and  13%  in  Southeast
sia [2].  The  global  list  of  41  countries  with  the
ighest  HIV—TB  burden  includes  India,  Indonesia,
yanmar and  Thailand  in  Asia  and  the  Paciﬁc
egion [1].
People with  HIV  and  TB  infection  are  much
ore likely  to  develop  active  TB.  Each  case  of
B—HIV co-infection  and/or  drug-resistant  tuber-
ulosis  severely  aggravates  the  global  TB  situation.
B is  a  leading  cause  of  death  in  HIV-infected  per-
ons, and  HIV  infection  is  the  most  potent  risk  factor
or developing  active  TB  disease  from  a  latent  TB
nfection  [2].
Worldwide,  if  we  consider  the  prevalence
f HIV—TB  co-infection,  there  is  an  approxi-
ately 41.2%  prevalence  in  Sub-Saharan  Africa  [3],
hereas the  prevalence  was  44%  in  2009  in  Kenya
4].  However,  China  has  a  relatively  low  prevalence
0.5%) of  co-infection  [5]. In  addition,  9%  of  TB
atients  were  HIV  positive  in  the  United  States  in
005 [6],  and  Vietnam  had  an  8.2%  prevalence  of  co-
nfection in  2010  [7]. Among  European  countries,
rance, Iceland  and  Portugal  have  reported  co-
nfection  prevalences  of  approximately  11—15%,
ut central  European  countries  have  reported  a
ower prevalence  (0—1%)  [8].
In India,  information  on  co-infection  remains
parse. Reports  from  the  cities/states  of  Delhi
9],  Tamil  Nadu  [10,11],  Maharashtra  (Mumbai
12],  Pune  [13]),  Jammu  and  Kashmir  [14],  Mad-
ya Pradesh  (Indore)  [15], Uttar  Pradesh  (Aligarh)
16],  Lucknow  [17], Karnataka  (Mangalore)  [18]
nd  Pondicherry  [19]  are  available  and  indicate
revalences ranging  from  <1%  to  approximately
0%.
Learning  the  prevalence  of  HIV-positive  infec-
ion in  active  TB  patients  is  imperative,  as  it  is
ncreasingly  being  recognized  that  such  information
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ould  encourage  planning  and  may  also  be  nec-
ssary for  determining  the  appropriate  treatment
egime. The  importance  of  HIV  surveillance  in  TB
atients  is  increasingly  being  realized  as  the  HIV
pidemic  continues  to  fuel  the  global  TB  epidemic.
n many  regions,  the  HIV  prevalence  in  TB  patients
s a  sensitive  indicator  of  the  spread  of  HIV  into
he general  population.  Information  about  the  HIV
revalence  in  TB  patients  is  essential  for  respon-
ing  with  an  increasing  commitment  to  providing
omprehensive HIV/AIDS  care  and  support,  includ-
ng anti-retroviral  therapy  (ART),  to  HIV-positive  TB
atients. Presently,  although  TB  cases  are  increas-
ngly being  detected  in  most  regions,  the  majority
f HIV  cases  are  not.  Current  knowledge  of  the
nteraction between  the  two  epidemics  in  a  given
rea is  restricted  to  individuals  who  are  able  to
ccess good  health  services  [1]. Therefore,  this
tudy was  planned  to  determine  the  prevalence
f HIV—TB  co-infection  in  patients  among  a  less
tudied population  of  Eastern  India  and  investigate
he distribution  of  HIV-positive  cases  among  pul-
onary  TB  and  extrapulmonary  TB  (EPTB)  patients.
n addition,  the  study  also  describes  various  clin-
cal presentations  among  these  co-infected  cases,
long with  a comparative  analysis  of several  earlier
tudies.
aterials and methods
his  cross-sectional  record  analysis  study  was  con-
ucted at  Central  Hospital  of  South  Eastern  Railway,
arden  Reach,  Kolkata,  India  from  January  2000  to
anuary 2012.  All  tuberculosis  patients  who  gave
onsent  for  HIV  testing  (after  pre-test  counsel-
ng) in  the  in-patient  and  out-patient  wards  of
he Department  of  Medicine  were  included  in  the
tudy. All  personal  information,  such  as  age,  gen-
er, socioeconomic  background,  education  level,
rofession,  sexual  preferences  and  promiscuity,  his-
ory of  past  surgery  or  blood  transfusion  were
ollected. The  diagnosis  of  tuberculosis  was  per-
ormed  using  clinical  examination  and  acid-fast
acillus (AFB)  sputum  smear,  chest  radiography,
ody ﬂuid  analysis  or  tissue  biopsy/FNAC  in  the
ase of  EPTB.  The  HIV-positive  cases  were  screened
sing an  initial  HIV  tridot  spot  test,  followed  by
epetitive  diagnostic  tests  using  a MICRO  ELISA
IV kit  (HIV-1  and  HIV-2  Ag).  The  following  exclu-
ion criteria  were  applied:  refusal  to  consent  to
IV screening,  patients  admitted  to  or  treated  by
ther specialties  and  those  outside  the  age  group
f 18—60  years.  Of  947  TB  cases,  406  cases  con-
ented to  HIV  testing  and  were  included  in  this
tudy.
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Table  1  HIV  co-infection  among  TB  patients.
Type  of  TB  HIV
positive
HIV
negative
Total TB
cases
PTBa 22  198  220
EPTBb 28  158  186
Total  HIV  Tested  50  356  406
UZL –Upper Zo ne  Lesion , MZL – Mid dle Zone  Lesion ,
LZL – Lower Zone Lesion CL – Cavitary Lesion, MM – Miliary Mottling
UZL, 63.6%
U+MZL,
9.0%
LZL, 4.5%
MM, 9%
CL, 13.6%
Figure  1  (Distribution  of  pulmonary  lesions  in  the  X-ray
ﬁndings).  UZL  —  Upper  zone  lesion,  MZL  —  middle  zone
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la PTB = pulmonary tuberculosis.
b EPTB = extrapulmonary tuberculosis.
Results
Of  the  406  TB  patients  included  in  this  study,  267
were males  and  139  were  females.  Fifty  (12.3%)
of these  patients  were  HIV  positive,  including  42
(10.3%) males  and  8  (2%)  females;  22  of  the  HIV-
positive  cases  had  pulmonary  TB,  whereas  28  cases
had EPTB  (Table  1).  The  most  commonly  affected
age group  was  31—45  years.
Of the  42  HIV—TB  co-infected  males,  30  (71.43%)
were ﬁeld  workers,  and  12  (28.57%)  were  ofﬁce
workers; all  8  affected  females  were  house-
wives. Forty-three  cases  (86%  of  the  50  HIV—TB
co-infected cases)  had  histories  of  heterosex-
ual relationships  with  more  than  1  partner;  2
(4%) patients  were  intravenous  drug  users  and  5
(10%) patients  had  past  histories  of  blood  transfu-
sion/surgery.
In terms  of  the  number  of  HIV—TB  co-infected
cases per  year,  the  maximum  number  of  5  cases/per
year occurred  in  2003,  2005,  2010  and  2011,
whereas the  lowest  number  of  cases  was  observed
in 2000,  with  1  case  of  HIV—TB  co-infection.
Of the  50  HIV-positive  cases,  45  (90%)  patients
presented with  cough;  39  (78%)  presented  with
fever;  38  (76%)  presented  with  loss  of  appetite;
38 (76%)  presented  with  weight  loss;  22  (44%)
presented with  dyspnea;  7  (14%)  presented  with
hemoptysis  and  5 (10%)  presented  with  chest  pain
(Table  2).Similarly,  among  the  50  HIV—TB  co-infected
cases, 22  (44%)  patients  suffered  from  pulmonary
TB, and  the  28  (56%)  remaining  patients  suffered
Table  2  Clinical  presentation  of  the  co-infected
patients.
Symptoms  Percentage  (%)
Cough  90
Fever  78
Loss  of  appetite  76
Weight  loss  76
Dyspnea  44
Hemoptysis  14
Chest  pain  10
U
f
c
i
2
Fesion,  LZL  —  lower  zone  lesion,  CL  —  cavitary  lesion,  MM
 miliary  mottling.
rom  EPTB.  Sixteen  (72.7%)  of  the  22  PTB  cases  dis-
layed AFB  positivity.  The  X-ray  ﬁndings  showed  the
ollowing pulmonary  lesion  distribution:  upper  zone
esions in  14  (63.6%)  cases,  upper  and  mid  zone
esions  in  2  (9%)  cases,  a  lower  zone  lesion  in  1
4.5%) case,  miliary  mottling  in  2 (9%)  cases  and
avitary  lesions  in  3  (13.6%)  cases  (Fig.  1).
Of the  28  EPTB  cases,  17  (60.7%)  patients  pre-
ented  with  pleural  effusion;  7  (25%)  presented
ith lymphadenopathy  (mediastinal,  cervical  and
bdominal);  1 (3.6%)  presented  with  CNS  TB;  2
7.1%) presented  with  pericardial  effusion  and  1
3.6%) presented  with  bone  TB  (Table  3).
iscussion
urveys  in  Africa,  Asia  and  the  Paciﬁc  have  indi-
ated that  the  HIV  prevalence  among  TB  patients  is
uch higher  than  that  observed  in  the  general  pop-
lation [20]. Sub-Saharan  Africa  has  a  prevalence
f HIV—TB  co-infection  of  approximately  41.2%  [3],
hereas the  prevalence  in  Kenya  has  decreased
rom 52%  in  2006  to  44%  in  2009  [4]. The  preva-
ence of  HIV  among  tuberculosis  patients  in  the
nited States  was  9%  in  2005  [6].  The  recorded  data
or 23  European  countries  over  several  years  indi-
ate that  the  HIV  prevalence  among  the  TB  patients
n England  increased  from  5%  in  2000  to  8%  in
005. In  contrast  to  the  higher  co-infection  rate  in
rance, Iceland  and  Portugal  (11—15%),  in  2008,  the
Table  3  Presentations  of  EPTB.
Extrapulmonary  presentation  of  TB  Percentage  (%)
Pleural  effusion  60.7
Lymphadenopathy  25.0
Pericardial  effusion  7.1
CNS  TB  3.6
Bone  TB  3.6
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entral  European  countries  reported  a  low  preva-
ence (0—1%)  [8].  A  similarly  low  prevalence  (0.5%)
as observed  in  China  in  2010  [5].  The  prevalence
f co-infection  was  8.2%  in  Vietnam  in  2010  [7],
ut the  prevalence  was  40%  in  Northern  Thailand
n 1996  [21].
In India,  the  prevalence  of  HIV  among  TB  patients
as generally  high  in  some  areas,  such  as  Mumbai
30%), Pune  (28.75%)  and  Mangalore  (21%),  com-
ared  with  areas  with  a  low  prevalence,  such  as
ew Delhi  (0.68%),  Jammu  and  Kashmir  (1.6%),  Ali-
arh (2.8%),  Indore  (4%)  and  Tamil  Nadu  (4.7%).
he present  study  indicates  a  prevalence  of  12.3%,
hich  more  or  less  reﬂects  the  prevalence  in  the
tates  of  Odisha,  Jharkhand  and  some  areas  of  West
engal, as  the  study  was  conducted  in  a  referral
ospital in  South  Eastern  Railway,  India.
There  was  a  trend  of  increasing  HIV  prevalence
n TB  patients  in  Aligarh  (from  0.8%  to  2.8%)  from
996 to  2001  [16]. A  similar  result  was  observed
n Goa,  indicating  a  rising  trend  in  HIV  prevalence
rom 2.01%  in  1995  to  10.91%  in  2000  [22]. The
resent  study  indicates  that  there  has  been  a  some-
hat imperceptible  change  in  the  prevalence  of
IV—TB co-infection.  This  change  in  co-infection
revalence  might  be  the  result  of  improvements  in
ublic awareness  and  better  treatment  regimes.
Except for  a  few  countries  in  Africa  (Sub-Saharan
frica), the  prevalence  of  co-infection  has  been
eported to  be  higher  among  males  than  females
3].  In  almost  all  other  countries,  there  is  little  dif-
erence in  the  gender  ratio.  Many  studies  that  have
een conducted  in  different  parts  of  India  have  indi-
ated signiﬁcantly  higher  numbers  of  male  subjects
ith  HIV—TB  co-infection  than  affected  females.
he ﬁndings  of  the  present  study  align  with  that
attern.  Moreover,  the  most  affected  age  group  in
his study  comprised  patients  aged  30—45  years.
lmost all  males  and  females  were  from  a  low  socio-
conomic  background.
Of  the  50  HIV—TB  co-infected  cases,  43  (86%)
atients had  histories  of  heterosexual  relationships
ith more  than  1 partner;  2  (4%)  patients  were
ntravenous drug  users  and  5  (10%)  patients  had  past
istories of  blood  transfusion/surgery.  In  the  Indian
cenario,  the  most  common  route  of  HIV  infection
as been  through  heterosexual  transmission  fol-
owed by  a  history  of  blood  transfusion  or  sharing
f needles  [15,16,23].  Homosexual  transmission  has
een rare  but  has  been  observed  in  a  few  places,
uch as  Gujarat  [23]. European  countries  have  dif-
erent transmission  modes  [8].  In  the  United  States,
he most  common  route  has  been  reported  to  be
ntravenous  drug  use  [6].
In this  study,  the  most  commonly  presented
ymptom was  cough  (90%),  followed  by  fever  (78%),
C
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eight  loss  (76%)  and  loss  of  appetite  (76%).  These
ndings  are  supported  by  other  studies  [23]. Fever
70.4%) was  the  most  common  symptom,  followed
y weight  loss  (65.2%)  and  cough  (42%)  in  another
tudy  [24].
HIV prevalence  has  been  observed  to  present
ore prominently  in  patients  with  pulmonary  TB  in
any studies  [9,16,18]. However,  other  researchers
23,24]  have  observed  that  HIV  prevalence  is
ore prominent  in  EPTB  patients.  However,  in  the
resent study,  EPTB  was  observed  to  be  the  more
rominent form  of  presentation,  which  may  most
ikely be  attributed  to  the  immune-compromised
tate  associated  with  HIV—TB  co-infection.  As  HIV-
elated immune-suppression  increases,  the  clinical
attern of TB  changes,  with  an  increasing  number
f EPTB  cases.  In  our  study,  the  most  common  form
f EPTB  was  pleural  effusion  (60.7%),  followed  by
ymphadenopathy  (25%)  (mediastinal,  cervical  and
bdominal)  and  pericardial  effusion  (7.1%).  Other
tudies have  reported  the  lymphatic  system  to  be
ore common  than  pleural  involvement  [23]. The
FB-positive  cases  displayed  a higher  HIV  preva-
ence (72.7%)  in  the  present  study,  whereas  in
ther studies,  AFB-negative  cases  have  displayed  a
reater HIV  prevalence.
The  tertiary  referral  Railways  hospital  in  which
he study  was  conducted  has  a catchment  area
hat includes  a  portion  of  West  Bengal,  Odisha  and
harkhand.  Therefore,  the  study  population  may
ot exactly  represent  the  general  population,  which
s one  limitation  of  this  study.  HIV  surveillance  in
ll TB  centers  in  these  areas  would  perhaps  better
eﬂect  the  general  population.
After  the  present  work  was  communicated,  a
ery recent  report  [25]  appeared  highlighting  the
ass economic  migration  in  India  and  its  likely
ffect  on  HIV  propagation.
In  summary,  the  prevalence  of  HIV—TB  co-
nfection was  12.3%,  and  co-infection  was  more
ommon  in  the  sexually  active  age  group.  Het-
rosexual transfer  is  the  most  common  mode  of
ransmission,  and  the  most  common  presenting
ymptom appears  to  be  cough.  EPTB  is more
ommon in  HIV-positive  cases  with  predominantly
leural effusion.  Thus,  all  TB  patients  should  be
uestioned  about  their  risk  factors  for  HIV  infection
nd counseled  to  undergo  HIV  testing.  Conversely,
ll HIV-positive  cases  should  be  screened  for  TB
ecause the  latter  may  cause  a  more  rapid  progres-
ion to  AIDS  unless  appropriately  treated  in  time.onﬂict of interest
one  declared.
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